New Hodgkin lymphoma treatment shines in clinical trial
"We hypothesized that the newer treatment would turn out to be most beneficial for patients, but the magnitude of the benefit exceeded our expectations."
Stay updated with breaking news from Jonathan Friedberg. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
"We hypothesized that the newer treatment would turn out to be most beneficial for patients, but the magnitude of the benefit exceeded our expectations."
Miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
A Phase 3 trial has demonstrated that patients with advanced stage (3 or 4) classic Hodgkin lymphoma who underwent initial treatment with nivolumab, a PD-1 checkpoint inhibitor, and AVD chemotherapy (N-AVD) had a significantly lower risk of their cancer getting worse than patients treated with brentuximab vedotin, a monoclonal antibody, and AVD (BV-AVD) a year after starting treatment.
A case is building for the routine use of dexrazoxane to protect the hearts of children with cancer being treated with doxorubicin.
A simple blood test that can tell whether you might have cancer in your body is available in New York State but doctors are still hesitant to prescribe it.